Stay updated on GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial

Sign up to get notified when there's something new on the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    An underlying site revision updated from v3.3.3 to v3.3.4; no study content changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:44:54.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer now displays Revision: v3.3.3. The HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 entry were removed.
    Difference
    0.1%
    Check dated 2025-12-23T08:33:23.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Minor site version update: Revision to v3.3.2 with no substantive changes to study details, eligibility criteria, or endpoints. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:25:12.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Minor editorial updates: PubMed publication notes now indicate automatic filling from PubMed and Revision: v3.3.1; the previous statement about PubMed publications and Revision: v3.2.0 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:42:36.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Removal of a site-wide government funding/operating status notice from the study page.
    Difference
    0.4%
    Check dated 2025-11-17T06:55:59.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Updates appear to be limited to metadata changes (dates, references); core study content remains unchanged, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:22:13.000Z thumbnail image

Stay in the know with updates to GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page.